Code | CSB-RA178519A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
WB | 1:500-1:5000 |
IHC | 1:50-1:200 |
The process of producing a CYP1A2 recombinant antibody consists of four main steps: firstly, sequencing the gene that codes for the CYP1A2 monoclonal antibody, secondly, cloning the gene into a plasmid vector, thirdly, introducing the recombinant vector into a host cell line, and finally, purifying the CYP1A2 recombinant monoclonal antibody from the cell culture supernatant through affinity chromatography. The CYP1A2 monoclonal antibody is derived from the CYP1A2 antibody-producing hybridomas and uses a synthesized peptide from the human CYP1A2 as the immunogen during this production process. This CYP1A2 recombinant monoclonal antibody has been recommended for use in ELISA, WB, and IHC applications for the detection of human CYP1A2 protein.
The CYP1A2 protein is a member of the cytochrome P450 family of enzymes and is primarily found in the liver. It plays a key role in the metabolism of various xenobiotics, including drugs, carcinogens, and environmental toxins. Specifically, CYP1A2 catalyzes the oxidation of substrates such as caffeine, theophylline, and acetaminophen, which helps to detoxify these compounds and make them more easily excreted from the body. Additionally, CYP1A2 has been implicated in the metabolism of endogenous compounds such as estrogens and melatonin.
There are currently no reviews for this product.